Dr Rob Clarke and the team at the Breast Cancer Now Research Unit in Manchester hope their work will lead to new drugs to treat aggressive types of breast cancer.
The research unit at the University of Manchester opened in 2008.
Manchester is one of the country’s leading centres for cancer research, and the Research Unit sits on the site of the Christie Hospital, one of the world’s top research hospitals. The Christie was involved in the earliest trials of tamoxifen and Herceptin (trastuzumab), which have gone on to become gold standard treatments for many thousands of breast cancer patients.
Under the leadership of Dr Rob Clarke, our team of scientists in Manchester are investigating the role played by a special type of cell called a ‘breast cancer stem cell’ in the growth and spread of the disease.
The team are also developing new models to help study breast cancer, with the aim that this will speed up progress towards new clinical trials investigating drugs for breast cancer prevention and treatment. Ultimately the researchers hope their work will lead to new cancer drugs which will help to fight the most aggressive types of breast cancer.